Hypha Labs (FUNI) Liabilities from Discontinued Operations (2022 - 2023)
Hypha Labs' (FUNI) quarterly Liabilities from Discontinued Operations came in at 308532.0 in Q4 2023, up 93.86% on a QoQ basis from 159156.0 in Q3 2023.
Hypha Labs (FUNI) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends
Hypha Labs (FUNI) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 308532.0 in Q4 2023.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 308532.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 308532.0 (changed N/A YoY) and the FY2023 annual result came in at 159156.0, down 66.65% from the prior year.
- Liabilities from Discontinued Operations improved to 308532.0 in Q4 2023, from 159156.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 557163.0 in Q1 2023 to a low of 159156.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Hypha Labs | 2.26 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 308,532.00 |
| Dec 31, 2023 | 308,532.00 |
| Sep 30, 2023 | 159,156.00 |
| Sep 30, 2023 | 159,156.00 |
| Jun 30, 2023 | 474,800.00 |
| Jun 30, 2023 | 474,800.00 |
| Mar 31, 2023 | 557,163.00 |
| Mar 31, 2023 | 557,163.00 |
| Sep 30, 2022 | 477,274.00 |
| Sep 30, 2022 | 477,274.00 |